180P 随机 NeoPembrOv 临床试验的免疫基因组分析表明，VEGFR2 血管生成轴是克服高级别卵巢癌免疫抗体的可行靶点

{"title":"180P 随机 NeoPembrOv 临床试验的免疫基因组分析表明，VEGFR2 血管生成轴是克服高级别卵巢癌免疫抗体的可行靶点","authors":"O. Le Saux, M. Ardin, J. Berthet, M. Bourhis, I. Treilleux, P-A. Just, G. Bataillon, A.M. Savoye, M-A. Mouret-Reynier, E. Coquan, O. Derbel, S. Bouizaguen, S.I. Labidi-Galy, E. Tartour, I. Galy-Fauroux, M-H. Stern, M. Terme, C. Caux, B. Dubois, I. Ray-Coquard","doi":"10.1016/j.iotech.2023.100639","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":" 12","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"180P Immunogenomic profiling of the randomized NeoPembrOv clinical trial reveals the VEGFR2 angiogenic axis as a promising actionable target to overcome immunoresistance of high-grade ovarian carcinomas\",\"authors\":\"O. Le Saux, M. Ardin, J. Berthet, M. Bourhis, I. Treilleux, P-A. Just, G. Bataillon, A.M. Savoye, M-A. Mouret-Reynier, E. Coquan, O. Derbel, S. Bouizaguen, S.I. Labidi-Galy, E. Tartour, I. Galy-Fauroux, M-H. Stern, M. Terme, C. Caux, B. Dubois, I. Ray-Coquard\",\"doi\":\"10.1016/j.iotech.2023.100639\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":192507,\"journal\":{\"name\":\"Immuno-Oncology and Technology\",\"volume\":\" 12\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immuno-Oncology and Technology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.iotech.2023.100639\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immuno-Oncology and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.iotech.2023.100639","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}